Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Elevance Health's 3-Year RORE % for the quarter that ended in Mar. 2024 was 1.84%.
The industry rank for Elevance Health's 3-Year RORE % or its related term are showing as below:
ELV's 3-Year RORE % is ranked worse than 52.63% of 19
companies
in the Healthcare Plans industry
Industry Median: 1.84
vs ELV: 1.84
Elevance Health 3-Year RORE % Historical Data
The historical data trend for Elevance Health's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Elevance Health's 3-Year RORE %
For the Healthcare Plans subindustry, Elevance Health's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health's 3-Year RORE % Distribution in the Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Elevance Health's 3-Year RORE % falls into.
Elevance Health 3-Year RORE % Calculation
Elevance Health's 3-Year RORE % for the quarter that ended in Mar. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2024 and 3-year before.
Elevance Health (NYSE:ELV) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Elevance Health 3-Year RORE % Related Terms
Thank you for viewing the detailed overview of Elevance Health's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.
Elevance Health (Elevance Health) Business Description
Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 48 million medical members as of June 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ELV has been successfully added to your 